Innovative Treatment for Degenerated Bioprosthetic Tricuspid Valves: Valve-in-Valve Approach

AHMET SEYFEDDİN GÜRBÜZ

doi:10.56752/Mevmedsci.2025.93

AHMET SEYFEDDİN GÜRBÜZ, YAKUP ALSANCAK, Nergiz AYDIN, Muhammed Fatih Kaleli, Hasan Kan

Year : 2025
Vol : 5
Issue : 2
Page : 75-78

DOI : 10.56752/Mevmedsci.2025.93

Transcatheter valve-in-valve (TVIV) implantation has emerged as a promising therapeutic option for patients with degenerated tricuspid bioprosthetic valves, particularly those deemed high-risk for traditional surgical approaches. Over time, degeneration of tricuspid bioprosthetic valves can lead to significant hemodynamic impairment, adversely affecting patients' quality of life. Conventional surgical interventions, while effective, are associated with substantial complications and prolonged recovery periods, especially in patients at elevated risk for cardiac surgery. In this report, we present the case of a patient who previously underwent bioprosthetic valve replacement for functional tricuspid insufficiency and presented with valve degeneration 10 years post-surgery. The patient was successfully treated with a TVIV procedure using a 29 mm Myval transcatheter heart valve (Meril Life Sciences, Vapi, Gujarat, India). Following the procedure, no complications were observed, and valve function significantly improved. This case illustrates the potential of TVIV as a viable alternative in managing degenerative bioprosthetic valve disease. It offers a safe and effective treatment modality, particularly for high-risk patients, thus avoiding the need for repeat surgical interventions. The favorable outcomes observed in this case further emphasize the growing role of TVIV in the treatment of bioprosthetic valve pathologies and its potential to improve outcomes in high-risk patient populations

Cite this Article As :

Description : Yazarların hiçbiri, bu makalede bahsedilen herhangi bir ürün, aygıt veya ilaç ile ilgili maddi çıkar ilişkisine sahip değildir. Araştırma, herhangi bir dış organizasyon tarafından desteklenmedi.Yazarlar çalışmanın birincil verilerine tam erişim izni vermek ve derginin talep ettiği takdirde verileri incelemesine izin vermeyi kabul etmektedirler. None of the authors, any product mentioned in this article, does not have a material interest in the device or drug. Research, not supported by any external organization. grant full access to the primary data and, if requested by the magazine they agree to allow the examination of data.

Innovative Treatment for Degenerated Bioprosthetic Tricuspid Valves: Valve-in-Valve Approach, Case Report,
2025, Vol. 5 (2)

Received : 16.12.2024, Accepted : 21.04.2025 , Published Online : 08.08.2025